The "4D Strategy" keynote speech by Douglas Goldstein, a practicalfuturist and president of eHealthcare.net, delivered a next-generation e-health road map for world leaders attending the International e-Health Association's first annual meeting, held earlier this month in Saudi Arabia.
4D Strategy is used by health systems and pharmaceutical organizations to address heath care paradigm shifts and disruptive innovations that challenge traditional revenue and profitability models. He told delegates that this is a "dynamic methodology that catalyzes and guides changes within enterprise organizations. It's a unique way to profile customer relationships, assess existing product portfolios, identify distinctive opportunites and support revenue growth with an organized system of 'distinctive innovations'."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze